National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines Committee for Follow-Up Testing for Metabolic Diseases Identified by Expanded Newborn Screening Using Tandem Mass Spectrometry
These include all reported relationships within the previous 2 years that may be relevant to the guidelines document.
|
|
|
Grant |
Other
Research Support |
Speakers Bureau |
Honoraria |
Expert Witness |
Ownership Interest |
Consultant Advisory Board |
Institution Employer |
Other Disclosures |
|
Bennett |
Significant (>$10K)/Other |
None |
None |
None |
None |
None |
None |
None |
None |
None |
|
Rinaldo |
Significant (>$10K)/Other |
Not reported |
Not reported |
Not reported |
Not reported |
Not reported |
Not reported |
Not reported |
Not reported |
Not reported |
|
Whitley |
Significant (>$10K)/Other |
None |
None |
None |
None |
None |
None |
None |
None |
None |
|
Rhead |
Significant (>$10K)/Other |
Pfizer |
None |
None |
None |
None |
None |
None |
None |
None |
|
Hannon |
Significant (>$10K)/Other |
None
|
None |
None |
None |
None |
None |
None |
None |
None |
|
Dietzen |
Significant (>$10K)/Other |
None |
None |
None |
None |
None |
None |
None |
None |
None |
|
Garg |
Significant (>$10K)/Other |
None |
None |
None |
None |
None |
None |
None |
None |
None |
|
Lo |
Significant (>$10K)/Other |
None |
None |
None |
None |
None |
None |
None |
None |
None |